OTC · CIK 0001514946
AXIM AXIM BIOTECHNOLOGIES, INC.
Insider trading from SEC Form 4. Last filing Oct 15, 2024.
AXIM BIOTECHNOLOGIES, INC. (AXIM) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on Oct 15, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at AXIM BIOTECHNOLOGIES, INC., scored.
Transactions
Every row filed, 1 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Catalina Valencia President and Director | POpen-market purchase Common Stock | +1,086,216 | - | - | 28,608,220 | Oct 15, 2024 |
Questions about AXIM
Answered from the filings on this page, as of the latest one.
Are insiders buying AXIM?
No. In the last 90 days no insider at AXIM BIOTECHNOLOGIES, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AXIM on the open market?
No open-market trade has been scored at AXIM BIOTECHNOLOGIES, INC.. The latest Form 4 on file was filed on Oct 15, 2024 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at AXIM BIOTECHNOLOGIES, INC.?
1 person has filed a Form 4 at AXIM BIOTECHNOLOGIES, INC., among them Catalina Valencia (President and Director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.